Point72 Asia Singapore Pte. Ltd. Buys New Shares in Danimer Scientific, Inc. (NYSE:DNMR)

Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Danimer Scientific, Inc. (NYSE:DNMR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 101,971 shares of the company’s stock, valued at approximately $62,000. Point72 Asia Singapore Pte. Ltd. owned approximately 0.09% of Danimer Scientific as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of DNMR. Privium Fund Management B.V. increased its holdings in Danimer Scientific by 67.6% in the 2nd quarter. Privium Fund Management B.V. now owns 75,398 shares of the company’s stock valued at $42,000 after acquiring an additional 30,398 shares during the last quarter. Diversified Trust Co increased its holdings in Danimer Scientific by 35.7% in the 2nd quarter. Diversified Trust Co now owns 285,000 shares of the company’s stock valued at $172,000 after acquiring an additional 75,000 shares during the last quarter. Virtu Financial LLC increased its holdings in Danimer Scientific by 628.5% in the 4th quarter. Virtu Financial LLC now owns 182,078 shares of the company’s stock valued at $186,000 after acquiring an additional 157,085 shares during the last quarter. Thomasville National Bank increased its holdings in Danimer Scientific by 125.8% in the 1st quarter. Thomasville National Bank now owns 177,845 shares of the company’s stock valued at $194,000 after acquiring an additional 99,078 shares during the last quarter. Finally, Greenlight Capital Inc. increased its holdings in Danimer Scientific by 5.1% in the 4th quarter. Greenlight Capital Inc. now owns 2,734,580 shares of the company’s stock valued at $2,789,000 after acquiring an additional 131,890 shares during the last quarter. Hedge funds and other institutional investors own 33.84% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on DNMR shares. TD Cowen downgraded shares of Danimer Scientific from a “buy” rating to a “hold” rating and reduced their price target for the company from $2.00 to $1.00 in a report on Tuesday, August 13th. Piper Sandler reduced their target price on shares of Danimer Scientific from $1.25 to $1.00 and set a “neutral” rating on the stock in a report on Wednesday, August 21st.

Danimer Scientific Stock Performance

Danimer Scientific stock opened at $0.50 on Friday. The company’s 50-day moving average price is $0.38 and its 200-day moving average price is $0.57. Danimer Scientific, Inc. has a twelve month low of $0.29 and a twelve month high of $1.84. The company has a quick ratio of 3.15, a current ratio of 4.52 and a debt-to-equity ratio of 1.65. The company has a market cap of $58.22 million, a PE ratio of -0.35 and a beta of 1.59.

Danimer Scientific (NYSE:DNMR) last posted its earnings results on Thursday, August 8th. The company reported ($0.18) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.06. Danimer Scientific had a negative net margin of 325.87% and a negative return on equity of 48.01%. The firm had revenue of $7.63 million for the quarter, compared to the consensus estimate of $8.40 million. On average, equities research analysts forecast that Danimer Scientific, Inc. will post -0.81 EPS for the current fiscal year.

Danimer Scientific Profile

Danimer Scientific, Inc, a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.